Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension

Journal of Hypertension

Volumn 14, Issue 6, 1996, Pages 799-805

  Luque, Manuel ^a   Martin, Piedad ^a   Martell, Nieves ^a   Fernandez, Carmen ^a   Brosnihan, K Bridget ^b   Ferrario, Carlos M ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin (1 7); Antihypertensive therapy; Captopril; Converting; Enzyme inhibitors; Essential hypertension; Prostacyclin

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ANGIOTENSIN; ANGIOTENSIN I; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; PROSTACYCLIN; PROSTAGLANDIN E2;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG MECHANISM; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE; HUMAN; MALE; PRIORITY JOURNAL; VENOUS BLOOD;

EID: 0029974215     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199606000-00017     Document Type: Article

References (35)

1. Chappell MC, Brosnihan KB, Welches WR, Ferrario CM: Characterization by high performance liquid chromatography of angiotensin peptides in the plasma and cerebrospinal fluid of the dog. Peptides 1987, 8:939-942.
2. Ferrario CM, Brosnihan KB, Diz DI, Jaiswal N, Khosla MC, Milsted A, et al.: Angiotensin-(1-7): a new hormone of the angiotensin system. Hypertension 1991, 18 (suppl III):III126-III133.
3. Schiavone MT, Santos RAS, Brosnihan KB, Khosla MC, Ferrario CM: Release of vasopressin from the rat hypothalamo neurohypophysial system by the angiotensin (1-7) heptapeptide. Proc Natl Acad Sci USA 1988, 85:4095-4098.
4. Felix D, Khosla MC, Barnes KL, Imboden H, Montani B, Ferrario CM: Neurophysiological responses to angiotensin-(1-7). Hypertension 1991, 17:1111-1114.
5. Barnes KL, Knowles WD, Ferrario CM: Angiotensin II and angiotensin-(1-7) excite neurons in the canine medulla in vitro. Brain Res Bull 1990, 24:275-280.
6. Jaiswal N, Tallant EA, Diz DI, Khosla MC, Ferrario CM: Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes. Hypertension 1991, 17:1115-1120.
7. Tallant EA, Jaiswal N, Diz DI, Ferrario CM: Human astrocytes contain two distinct angiotensin receptor subtypes. Hypertension 1991, 18:32-39.
8. Jaiswal N, Diz DI, Chappell MC, Khosla MC, Ferrario CM: Stimulation of endothelial cell prostaglandin production by angiotensin peptides: characterization of receptors. Hypertension 1992, 19 (suppl II):II49-II55.
9. Jaiswal N, Tallant EA, Jaiswal RK, Diz DI, Ferrario CM: Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved. J Pharmacol Exp Ther 1993, 265:664-673.
10. Ferrario CM: Biological roles of angiotensin-(1-7). Hypertens Res 1992, 15:61-66.
11. Kohara K, Brosnihan KB, Ferrario CM: Angiotensin-(1-7) in the spontaneously hypertensive rat. Peptides 1993, 14:883-891.
12. Ferrario CM, Jaiswal N, Yamamoto K, Diz DI, Schiavone MT: Hypertensive mechanisms and converting enzyme inhibitors. Clin Cardiol 1991, 14 (suppl IV):IV56-IV62.
13. Benter IF, Ferrario CM, Morris M, Diz DI: Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol 1995, 269:H313-H319.
14. Benter IF, Diz DI, Ferrario CM: Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7). Hypertension 1995, 26:1138-1144.
15. Senanayake PD, Moriguchi A, Kumagai H, Ganten D, Ferrario CM, Brosnihan KB: Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides 1994, 15:919-926.
16. Nakamoto H, Ferrario CM, Fuller SB, Robaczewski DL, Winicov E, Dean RH: Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension 1995, 25:796-802.
17. Kohara K, Tabuchi Y, Senanayake P, Brosnihan KB, Ferrario CM: Reassessment of plasma angiotensins measurement: effects of protease inhibitors and sampling handling procedures. Peptides 1991, 12:1135-1141.
18. Santos RAS, Brum J, Brosnihan KB, Ferrario CM: The renin-angiotensin system during acute myocardlal ischemia in dogs. Hypertension 1990, 15 (suppl I):I121-I127.
19. Jaiswal N, Diz DI, Tallant EA, Khosla MC, Ferrario CM: The non-peptide angiotensin II antagonist DuP753 is a potent stimulus for prostacyclin release. Am J Hypertens 1991, 4:228-233.
20. Jaiswal N, Malik KU: Prostaglandin synthesis elicited by cholinergic stimuli is mediated by activation of M2 muscarinic receptors in rabbit heart. J Pharmacol Exp Ther 1988, 245:59-66.
21. Leffler CW, Malik KU: Prostaglandin synthesis elicited by cholinergic stimuli is mediated by activation of M2 muscarinic receptors in rabbit heart. Circ Res 1985, 57:689-694.
22. Azizi M, Chatellier G, Guyene TT, Geoffroy DM, Menard J: Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Circulation 1995, 92:825-834.
23. Campbell DJ, Kladis A, Duncan AM: Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 1994, 23:439-449.
24. Juillerat L, Nussberger J, Menard J, Mooser V, Christen Y, Waeber B, et al.: Determinants of angiotensin II generation during converting enzyme inhibition. Hypertension 1990, 16:564-572.
25. Brunner HR, Waeber B, Nussberger J: What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition. J Hypertens 1988, 6 (suppl 3):S1-S5.
26. Mento PF, Wilkes BM: Plasma angiotensins and blood pressure during converting enzyme inhibition. Hypertension 1987, 9 (suppl III):III42-III48.
27. Mento PF, Holt WF, Murphy WR, Wilkes BM: Combined renin and converting enzyme inhibition in rats. Hypertension 1989, 13:741-748.
28. Nussberger J, Brunner DB, Waeber B, Brunner HR: True versus immunoreactive angiotensin II in human plasma. Hypertension 1985, 7 (suppl I):I1-I7.
29. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A: Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 1990, 265:22348-22357.
30. Lawrence AC, Evin G, Kladis A, Campbell DJ: An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-terminal-directed antisera: measurement of eight angiotensin peptides in human plasma. J Hypertens 1990, 8:715-724.
31. Welches WR, Brosnihan KB, Ferrario CM: A comparison of the properties, and enzymatic activity of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci 1993, 53:1461-1480.
32. Paula RD, Lima CV, Khosla MC, Santos RAS: Angiotensin-(1-7) potentiates the hypertensive effect of bradykinin in conscious rats. Hypertension 1995, 26:1154-1159.
33. Moriguchi A, Tallant EA, Matsumura K, Reilly TM, Walton H, Ganten D, et al.: Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats. Hypertension 1995, 25:1260-1265.
34. Porsti I, Bara AT, Busse R, Hecker M: Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: Implications for a novel angiotensin receptor. Br J Pharmacol 1994, 111:652-654.
35. Brosnihan KB, Li, Ferrario CM: Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996, 27:523-528.